BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34061353)

  • 1. Risk factors for an advanced breast cancer diagnosis within 2 years of a negative mammogram.
    McCarthy AM; Ehsan S; Appel S; Welch M; He W; Bahl M; Chen J; Lehman CD; Armstrong K
    Cancer; 2021 Sep; 127(18):3334-3342. PubMed ID: 34061353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.
    Neuhouser ML; Aragaki AK; Prentice RL; Manson JE; Chlebowski R; Carty CL; Ochs-Balcom HM; Thomson CA; Caan BJ; Tinker LF; Urrutia RP; Knudtson J; Anderson GL
    JAMA Oncol; 2015 Aug; 1(5):611-21. PubMed ID: 26182172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biennial versus annual mammography and the risk of late-stage breast cancer.
    White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
    J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body mass index, mammographic density, and breast cancer risk by estrogen receptor subtype.
    Shieh Y; Scott CG; Jensen MR; Norman AD; Bertrand KA; Pankratz VS; Brandt KR; Visscher DW; Shepherd JA; Tamimi RM; Vachon CM; Kerlikowske K
    Breast Cancer Res; 2019 Apr; 21(1):48. PubMed ID: 30944014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Mortality Among Participants of Women's Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers.
    Irvin VL; Zhang Z; Simon MS; Chlebowski RT; Luoh SW; Shadyab AH; Krok-Schoen JL; Tabung FK; Qi L; Stefanick ML; Schedin P; Jindal S
    JAMA Netw Open; 2020 Jun; 3(6):e207227. PubMed ID: 32602908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of mammogram acquisition on the mammographic density and breast cancer association in the Mayo Mammography Health Study cohort.
    Olson JE; Sellers TA; Scott CG; Schueler BA; Brandt KR; Serie DJ; Jensen MR; Wu FF; Morton MJ; Heine JJ; Couch FJ; Pankratz VS; Vachon CM
    Breast Cancer Res; 2012 Nov; 14(6):R147. PubMed ID: 23152984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of established risk factors with breast cancer subtypes.
    McCarthy AM; Friebel-Klingner T; Ehsan S; He W; Welch M; Chen J; Kontos D; Domchek SM; Conant EF; Semine A; Hughes K; Bardia A; Lehman C; Armstrong K
    Cancer Med; 2021 Sep; 10(18):6456-6467. PubMed ID: 34464510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity, mammography use and accuracy, and advanced breast cancer risk.
    Kerlikowske K; Walker R; Miglioretti DL; Desai A; Ballard-Barbash R; Buist DS
    J Natl Cancer Inst; 2008 Dec; 100(23):1724-33. PubMed ID: 19033562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cumulative Advanced Breast Cancer Risk Prediction Model Developed in a Screening Mammography Population.
    Kerlikowske K; Chen S; Golmakani MK; Sprague BL; Tice JA; Tosteson ANA; Rauscher GH; Henderson LM; Buist DSM; Lee JM; Gard CC; Miglioretti DL
    J Natl Cancer Inst; 2022 May; 114(5):676-685. PubMed ID: 35026019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Risk of Developing Breast Cancer after a False-Positive Screening Mammogram.
    Henderson LM; Hubbard RA; Sprague BL; Zhu W; Kerlikowske K
    Cancer Epidemiol Biomarkers Prev; 2015 Dec; 24(12):1882-9. PubMed ID: 26631292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammography interval and breast cancer mortality in women over the age of 75.
    Simon MS; Wassertheil-Smoller S; Thomson CA; Ray RM; Hubbell FA; Lessin L; Lane DS; Kuller LH
    Breast Cancer Res Treat; 2014 Nov; 148(1):187-95. PubMed ID: 25261290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of a False-Positive Screening Mammogram on Subsequent Screening Behavior and Stage at Breast Cancer Diagnosis.
    Dabbous FM; Dolecek TA; Berbaum ML; Friedewald SM; Summerfelt WT; Hoskins K; Rauscher GH
    Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):397-403. PubMed ID: 28183826
    [No Abstract]   [Full Text] [Related]  

  • 13. Prospective breast cancer risk prediction model for women undergoing screening mammography.
    Barlow WE; White E; Ballard-Barbash R; Vacek PM; Titus-Ernstoff L; Carney PA; Tice JA; Buist DS; Geller BM; Rosenberg R; Yankaskas BC; Kerlikowske K
    J Natl Cancer Inst; 2006 Sep; 98(17):1204-14. PubMed ID: 16954473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study.
    Nederend J; Duijm LE; Voogd AC; Groenewoud JH; Jansen FH; Louwman MW
    Breast Cancer Res; 2012 Jan; 14(1):R10. PubMed ID: 22230363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late-stage breast cancer among women with recent negative screening mammography: do clinical encounters offer opportunity for earlier detection?
    Mouchawar J; Taplin S; Ichikawa L; Barlow WE; Geiger AM; Weinmann S; Gilbert J; Manos MM; Ulcickas Yood M
    J Natl Cancer Inst Monogr; 2005; (35):39-46. PubMed ID: 16287884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers.
    Mandelson MT; Oestreicher N; Porter PL; White D; Finder CA; Taplin SH; White E
    J Natl Cancer Inst; 2000 Jul; 92(13):1081-7. PubMed ID: 10880551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting interval and screen-detected breast cancers from mammographic density defined by different brightness thresholds.
    Nguyen TL; Aung YK; Li S; Trinh NH; Evans CF; Baglietto L; Krishnan K; Dite GS; Stone J; English DR; Song YM; Sung J; Jenkins MA; Southey MC; Giles GG; Hopper JL
    Breast Cancer Res; 2018 Dec; 20(1):152. PubMed ID: 30545395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term prognostic implications of risk factors associated with tumor size: a case study of women regularly attending screening.
    Strand F; Humphreys K; Holm J; Eriksson M; Törnberg S; Hall P; Azavedo E; Czene K
    Breast Cancer Res; 2018 Apr; 20(1):31. PubMed ID: 29669579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combined effect of mammographic texture and density on breast cancer risk: a cohort study.
    Wanders JOP; van Gils CH; Karssemeijer N; Holland K; Kallenberg M; Peeters PHM; Nielsen M; Lillholm M
    Breast Cancer Res; 2018 May; 20(1):36. PubMed ID: 29720220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of false-positive mammograms on interval breast cancer screening in a health maintenance organization.
    Burman ML; Taplin SH; Herta DF; Elmore JG
    Ann Intern Med; 1999 Jul; 131(1):1-6. PubMed ID: 10391809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.